SCHEMBL6838642

SCHEMBL6838642

FC(F)(F)c1nc2ccccc2c2c1nc(-c1ccccc1)n2CCN1CCNCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
TSHR P16473 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ADRB2 P07550 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HPGD P15428 6/20 0.37
KDM4E B2RXH2 6/20 0.37
CYP3A4 P08684 5/20 0.37
HSD17B10 Q99714 5/20 0.37
CYP1A2 P05177 1/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
ABCC1 P33527 2/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839980 0.90 ADRB2 (0.39) ALDH1A1TSHRSMN1; SMN2ADRB2MEN1
SCHEMBL6833702 0.90 SLC6A2 (0.39) ALDH1A1TSHRSMN1; SMN2ADRB2HPGD
SCHEMBL6837641 0.90 EGFR (0.42) ALDH1A1TSHRSMN1; SMN2ADRB2KMT2A
SCHEMBL6833824 0.88 KDM4E (0.38) ALDH1A1TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL6834043 0.87 ADRB2 (0.37) ALDH1A1TSHRSMN1; SMN2ADRB2KDM4E
SCHEMBL6833713 0.84 NPY1R (0.39) ADRB2CYP1A2
SCHEMBL6927698 0.84 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL6838696 0.83 NPY1R (0.40) ADRB2CYP1A2
SCHEMBL6837676 0.81 EGFR (0.42) ALDH1A1TSHRSMN1; SMN2KMT2AGAA
SCHEMBL6840139 0.80 ACP1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 ALDH1A1 504/4885TSHR 1717/4885SMN1; SMN2 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.